Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure.

Curtis LH, Mi X, Qualls LG, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Setoguchi S, Hernandez AF, Fonarow GC.

Am Heart J. 2012 Jun;163(6):946-953.e1. doi: 10.1016/j.ahj.2012.03.007. Epub 2012 May 9.

PMID:
22709746
2.

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.

Ezekowitz JA, McAlister FA.

Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Review.

PMID:
19066207
3.

Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.

Dieterich HA, Wendt C, Saborowski F.

Fiziol Cheloveka. 2005 Nov-Dec;31(6):97-105. Review.

PMID:
16366159
4.

Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure.

McKenna C, Walker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S.

Value Health. 2012 May;15(3):420-8. doi: 10.1016/j.jval.2012.01.004. Epub 2012 Mar 29. Review.

5.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
6.

Roadmap to inpatient heart failure management.

Vaduganathan M, Gheorghiade M.

J Cardiol. 2015 Jan;65(1):26-31. doi: 10.1016/j.jjcc.2014.08.011. Epub 2014 Sep 16. Review.

7.

Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.

van der Wal HH, Grote Beverborg N, van Veldhuisen DJ, Voors AA, van der Meer P.

Expert Opin Pharmacother. 2016 Aug;17(11):1527-38. doi: 10.1080/14656566.2016.1197201. Epub 2016 Jun 13. Review.

PMID:
27254409

Supplemental Content

Support Center